World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
55
Citations
12034
World Ranking
3795
National Ranking
1740

Overview

Suryaprakash Sambhara is affiliated with the Centers for Disease Control and Prevention in the United States. Their research spans across multiple fields, notably Medicine and Immunology and Microbiology. Within these broader areas, their work focuses particularly on subfields such as Epidemiology, Immunology, Infectious Diseases, Molecular Biology, and Genetics.

The main areas of research undertaken by Sambhara include Influenza Virus Research Studies, Respiratory Viral Infections Research, Viral Gastroenteritis Research and Epidemiology, Immune Cell Function and Interaction, SARS-CoV-2 and COVID-19 Research, Monoclonal and Polyclonal Antibodies Research, and interferon and immune responses.

Recent publications by Sambhara demonstrate active contributions to the field. Selected papers include:

  • Prevalent, protective, and convergent IgG recognition of SARS-CoV-2 non-RBD spike epitopes, 2021, Science
  • Antiviral Approaches against Influenza Virus, 2023, Clinical Microbiology Reviews
  • SARS-CoV-2 RBD Neutralizing Antibody Induction is Enhanced by Particulate Vaccination, 2020, Advanced Materials
  • Progress towards the Development of a Universal Influenza Vaccine, 2022, Viruses
  • Adenoviral Vector-Based Vaccine Platforms for Developing the Next Generation of Influenza Vaccines, 2020, Vaccines

Sambhara frequently collaborates with other researchers, with notable coauthors including Shivaprakash Gangappa, Amrita Kumar, Margarita Mishina, Suresh K. Mittal, and Weiping Cao. This network reflects a consistent collaborative trend in their publications.

Regarding publication venues, Sambhara has published multiple times in journals such as Viruses, Vaccines, Advanced Materials, bioRxiv (Cold Spring Harbor Laboratory), and Clinical Infectious Diseases.

Best Publications

  • Persistence of Memory CD8 T Cells in MHC Class I-Deficient Mice

    Kaja Murali-Krishna;Lisa L. Lau;Suryaprakash Sambhara;Francois Lemonnier

  • Normal development and function of CD8+ cells but markedly decreased helper cell activity in mice lacking CD4.

    A. Rahemtulla;W. P. Fung-Leung;M. W. Schilham;T. M. Kündig

  • Cutting Edge: Impaired Toll-Like Receptor Expression and Function in Aging

    Mary Renshaw;Julie Rockwell;Carrie Engleman;Andrew Gewirtz

  • Innate immunity in aging: impact on macrophage function

    Julie Plowden;Mary Renshaw-Hoelscher;Carrie Engleman;Jacqueline Katz

  • Role of Host Cytokine Responses in the Pathogenesis of Avian H5N1 Influenza Viruses in Mice

    Kristy J. Szretter;Shivaprakash Gangappa;Xuihua Lu;Chalanda Smith

  • NLRX1 Protein Attenuates Inflammatory Responses to Infection by Interfering with the RIG-I-MAVS and TRAF6-NF-κB Signaling Pathways

    Irving C. Allen;Chris B. Moore;Monika Schneider;Yu Lei

  • Critical role of an antiviral stress granule containing RIG-I and PKR in viral detection and innate immunity.

    Koji Onomoto;Michihiko Jogi;Michihiko Jogi;Ji-Seung Yoo;Ryo Narita

  • NS1 protein of influenza A virus inhibits the function of intracytoplasmic pathogen sensor, RIG-I.

    Zhu Guo;Li-mei Chen;Hui Zeng;Jorge A. Gomez

  • Development of adenoviral-vector-based pandemic influenza vaccine against antigenically distinct human H5N1 strains in mice

    Mary A Hoelscher;Sanjay Garg;Dinesh S Bangari;Jessica A Belser

  • Challenges for vaccination in the elderly

    Richard Aspinall;Giuseppe Del Giudice;Rita B Effros;Beatrix Grubeck-Loebenstein

  • Prevalent, protective, and convergent IgG recognition of SARS-CoV-2 non-RBD spike epitopes.

    William N. Voss;Yixuan J. Hou;Nicole V. Johnson;George Delidakis

  • DNA vaccine expressing conserved influenza virus proteins protective against H5N1 challenge infection in mice.

    Suzanne L. Epstein;Terrence M. Tumpey;Julia A. Misplon;Chia-Yun Lo

  • Protection against respiratory syncytial virus infection by DNA immunization.

    Xiaomao Li;Suryaprakash Sambhara;Cindy Xin Li;Mary Ewasyshyn

  • Heterosubtypic Immunity against Human Influenza A Viruses, Including Recently Emerged Avian H5 and H9 Viruses, Induced by FLU–ISCOM Vaccine in Mice Requires both Cytotoxic T-Lymphocyte and Macrophage Function

    Suryaprakash Sambhara;Anjna Kurichh;Renata Miranda;Terrence Tumpey

  • Influenza virus exploits tunneling nanotubes for cell-to-cell spread

    Amrita Kumar;Jin Hyang Kim;Priya Ranjan;Maureen G. Metcalfe

  • Cytokine and Chemokine Profiles in Lung Tissues from Fatal Cases of 2009 Pandemic Influenza A (H1N1): Role of the Host Immune Response in Pathogenesis

    Rongbao Gao;Julu Bhatnagar;Dianna M. Blau;Patricia Greer

  • Protein Energy Malnutrition Decreases Immunity and Increases Susceptibility to Influenza Infection in Mice

    Andrew K. Taylor;Weiping Cao;Keyur P. Vora;Juan De La Cruz

  • Antiviral Approaches against Influenza Virus

    Unknown

  • Immunosenescence and Challenges of Vaccination against Influenza in the Aging Population.

    Adrian J. Reber;Tatiana Chirkova;Jin Hyang Kim;Weiping Cao

  • Early Control of H5N1 Influenza Virus Replication by the Type I Interferon Response in Mice

    Kristy J. Szretter;Shivaprakash Gangappa;Jessica A. Belser;Hui Zeng

  • Cytotoxic T lymphocyte reactivity to gp100, MelanA/MART-1, and tyrosinase, in HLA-A2-positive vitiligo patients.

    Rochelle L. Mandelcorn-Monson;Neil H. Shear;Eddy Yau;Suryaprakash Sambhara

Frequent Co-Authors

Jacqueline M. Katz
Jacqueline M. Katz Emory University
Suresh K. Mittal
Suresh K. Mittal Purdue University West Lafayette
Takashi Fujita
Takashi Fujita Kyoto University
David K. Shay
David K. Shay Centers for Disease Control and Prevention
Sherif R. Zaki
Sherif R. Zaki Centers for Disease Control and Prevention
Wun-Ju Shieh
Wun-Ju Shieh Centers for Disease Control and Prevention
Nancy J. Cox
Nancy J. Cox Vanderbilt University Medical Center
Mark G. Thompson
Mark G. Thompson Centers for Disease Control and Prevention
Adolfo García-Sastre
Adolfo García-Sastre Icahn School of Medicine at Mount Sinai
James Stevens
James Stevens National Center for Immunization and Respiratory Diseases

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, related healthcare careers often involve advanced nursing roles that combine clinical expertise with immunologic knowledge. Many professionals choose to enhance their qualifications through specialized programs, such as acute care nurse practitioner programs, which prepare nurses to manage complex patient cases requiring immunological insight.

The demand for qualified nurse practitioners has led to the development of accelerated NP programs, allowing students to complete their studies more quickly while maintaining rigorous training standards. These programs are especially appealing for those transitioning from other healthcare fields who want to focus on immunology-related specialties.

For individuals without a nursing background, there are 12-month accelerated nursing programs online for non nurses that open the door to a nursing career with a focus on immunology and related sciences. These streamlined programs can significantly shorten the time needed to enter the healthcare workforce.

Understanding the financial landscape is also important. Exploring how much do DNP nurses make can provide valuable insights into potential earnings across different states, helping you make informed decisions about your educational and career pathways in the field of Immunology and advanced nursing practice.

Best Scientists Citing Suryaprakash Sambhara

Trending Scientists

Recently Published Articles